Many cancers show CS-E overexpression (201, 202), which allows for increased binding of vascular endothelial growth factor (VEGF) in ovarian adenocarcinomas (203), negative regulation of Wnt/β-catenin signaling in breast cancer (204), and increased metastasis of Lewis Lung carcinoma (201). Here, VEGFA is linked to breast cancer.